Skip to content
OpenCapital
Get started

Identive INVE Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By geography

See full
Americas73%+73.8%
Europe And Middle East19%-44.1%
Asia Pacific8%-66.7%

Other financials

Income statement

See full
Revenue$7.4M+40.7%
Gross profit$1.3M+878%
Operating income-$4.2M+23.1%
Net income-$3.4M+28.0%
EPS (diluted)-$0.15+28.6%

Balance sheet

See full
Cash & equivalents$124.5M-5.9%
Total debt$730.0K-59.8%
Total equity$137.2M-8.9%
Total assets$147.6M-7.0%

Cash flow

See full
Operating cash flow-$2.8M+13.6%
CapEx$882.0K+193%
Free cash flow-$3.7M-3.8%

Valuation

See full
Market cap$60.5M-17.4%
Enterprise value-$63.3M+17.9%
P/S2.6×-0.5×

Profitability

See full
Gross margin10.4%—
Operating margin-88.4%-15.6pp
Net margin-70.5%-367pp
FCF margin-78%—

Returns & leverage

See full
Return on equity-11.6%-79.5pp
Debt / equity0×0.0×
Current ratio14.9×-5.6×